NASDAQ:RDNT - Nasdaq - US7504911022 - Common Stock - Currency: USD
52.21
-0.17 (-0.32%)
The current stock price of RDNT is 52.21 USD. In the past month the price decreased by -0.57%. In the past year, price increased by 1.97%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.26 | 90.87B | ||
CVS | CVS HEALTH CORP | 12.81 | 87.67B | ||
LH | LABCORP HOLDINGS INC | 16.38 | 20.19B | ||
DGX | QUEST DIAGNOSTICS INC | 19.29 | 19.79B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 13.52 | 14.68B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 116.78 | 11.24B | ||
DVA | DAVITA INC | 14.78 | 11.24B | ||
CHE | CHEMED CORP | 24.34 | 8.38B | ||
HIMS | HIMS & HERS HEALTH INC | 66.96 | 8.03B | ||
GH | GUARDANT HEALTH INC | N/A | 6.03B | ||
CRVL | CORVEL CORP | 26.07 | 5.60B | ||
OPCH | OPTION CARE HEALTH INC | 23.65 | 5.28B |
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 8,546 full-time employees. The company went IPO on 2001-12-12. The company has a network of 398 owned and/or operated outpatient imaging centers. The Company’s Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company’s Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. This segment also designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.
RADNET INC
1510 Cotner Ave
Los Angeles CALIFORNIA 90025 US
CEO: Howard G. Berger
Employees: 8157
Company Website: https://www.radnet.com/
Investor Relations: https://www.radnet.com/about-radnet/investor-relations
Phone: 13104787808
The current stock price of RDNT is 52.21 USD. The price decreased by -0.32% in the last trading session.
The exchange symbol of RADNET INC is RDNT and it is listed on the Nasdaq exchange.
RDNT stock is listed on the Nasdaq exchange.
12 analysts have analysed RDNT and the average price target is 73.1 USD. This implies a price increase of 40.01% is expected in the next year compared to the current price of 52.21. Check the RADNET INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
RADNET INC (RDNT) has a market capitalization of 3.91B USD. This makes RDNT a Mid Cap stock.
RADNET INC (RDNT) currently has 8157 employees.
RADNET INC (RDNT) has a support level at 51.55 and a resistance level at 53.42. Check the full technical report for a detailed analysis of RDNT support and resistance levels.
The Revenue of RADNET INC (RDNT) is expected to grow by 6.53% in the next year. Check the estimates tab for more information on the RDNT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RDNT does not pay a dividend.
RADNET INC (RDNT) will report earnings on 2025-05-11, before the market open.
The PE ratio for RADNET INC (RDNT) is 82.87. This is based on the reported non-GAAP earnings per share of 0.63 and the current share price of 52.21 USD. Check the full fundamental report for a full analysis of the valuation metrics for RDNT.
The outstanding short interest for RADNET INC (RDNT) is 9.84% of its float. Check the ownership tab for more information on the RDNT short interest.
ChartMill assigns a technical rating of 1 / 10 to RDNT. When comparing the yearly performance of all stocks, RDNT is a bad performer in the overall market: 65.98% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to RDNT. RDNT has only an average score on both its financial health and profitability.
Over the last trailing twelve months RDNT reported a non-GAAP Earnings per Share(EPS) of 0.63. The EPS increased by 26% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.15% | ||
ROA | 0.08% | ||
ROE | 0.31% | ||
Debt/Equity | 1.1 |
ChartMill assigns a Buy % Consensus number of 87% to RDNT. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of -29.14% and a revenue growth 6.53% for RDNT